Navigation Links
Microarray provides 3 genomic guides to breast cancer treatment decisions
Date:9/7/2007

HOUSTON - Three genomic tests separately predict the likelihood that a patient's breast cancer will reoccur after surgery without additional treatment, and the cancer's vulnerability to chemotherapy or hormone therapy, researchers at The University of Texas M. D. Anderson Cancer Center report at the first American Society of Clinical Oncology ASCO Breast Cancer Symposium Sept. 7-8 in San Francisco.

Each predictor - of prognosis, of sensitivity to chemotherapy and sensitivity to hormone therapy - is independent of the others, providing unique information to physicians and patients considering treatment options, says W. Fraser Symmans, M.D., professor in M. D. Anderson's Department of Pathology.

"Existing genomic tests for breast cancer provide information about future risk in general, but not the likely benefit of each treatment option separate from a patient's overall prognosis if no treatment followed surgery. It is important to independently assess these three variables," Symmans says.

Symmans and Lajos Pusztai, M.D., Ph.D., associate professor in M. D. Anderson's Department of Breast Medical Oncology will present two research updates on the genomic predictors, which can be reported from a single microarray analysis of a needle biopsy of a patient's breast cancer.

Symmans will present results from two studies involving 960 patients validating a 200-gene index that predicts a patient's response to hormone-suppressing therapy. About 70 percent of breast cancers express the estrogen receptor (ER), indicating that their growth is fueled to some extent by the female hormone estrogen. Anti-estrogen therapies such as tamoxifen only benefit about half of these patients. The challenge is to predict exactly who will be helped and who should seek additional treatment.

In the two studies the Sensitivity to Endocrine Therapy (SET) Index score predicted distant relapse free survival among 453 patients who received tamoxifen
'/>"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Acupuncture provides relief
2. Micro-camera provides new breast imaging technique
3. MicroRNA provides new insight into birth defects
4. Hormone therapy provides no heart benefit
5. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
6. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
7. Cholesterol provides immunity against infection by certain parasites
8. John Hopkins CGHH program provides Global Health education
9. Protein provides antioxidant protection to Neurons
10. London Hospital Provides Specialized Care For Pregnant Women
11. Study Provides Evidence That Obesity Leads To A More Aggressive Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Royal River Natural Foods, a locally-owned independent ... that found adults who got the most magnesium were less ... to those who got the least magnesium, with the largest ... report is part of the March 2015 issue of “ ... Foods publishes free each month for the Freeport community to ...
(Date:2/27/2015)... IL (PRWEB) February 27, 2015 According ... Lutheran General Hospital on June 25, 2013 and underwent ... her stomach through her mouth. Because the duodenoscope ... infected with the antibiotic-resistant “superbug” carbapenem-resistant Enterobacteriaceae (CRE). ... Circuit Court of Cook County on behalf of Ms. ...
(Date:2/27/2015)... Washington DC (PRWEB) February 27, 2015 ... and Means Committee, includes a pharmacy provision to ... from crossing the pharmacy counter. The Protecting the ... and Means Health Subcommittee Chairman Kevin Brady (R-TX) ... need to address the prescription drug abuse epidemic ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Winter is here, ... on human skin, exposure to snow and ice can be ... also hurt dogs’ paws. The Puppy Store is ready to ... keep their dogs safe in the winter time. , Ice ... vomiting, diarrhea and other symptoms. Ingestion of ice melt products ...
(Date:2/27/2015)... The Dawn Greene Hospice, a 10-bed facility located on ... the Upper East Side, was officially dedicated and blessed at ... Timothy Michael Cardinal Dolan. , Thomas J. Fahey, Jr., MD, ... member of the ArchCare Board of Trustees, presided over the ... director of MMW, and Christina McInerney, president and CEO of ...
Breaking Medicine News(10 mins):Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3
... Extension of the Philadelphia Ronald McDonald House, will ... House-Lighting Ceremony on, Thursday, January 3rd; ... PHILADELPHIA, Dec. 28 The 27,000-square-foot,three-story "Philadelphia ... open its doors on Monday, January 7, 2008 ...
... To Renew and Fulfill Their,Resolutions, NEW YORK, Dec. ... fail after two months., In an effort to ... resolutions, the Healthy Monday initiative, an organization that,dedicates Monday ... a unique New Year,s idea to all Americans., ...
... farm women has shown that contact with some commonly used ... asthma. , Farm women are an understudied occupational group, ... Health Sciences and lead author of the study. More than ... is very little known about the risks. , The study ...
... attributed to pilot error significantly declined between 1983 and ... the Johns Hopkins Bloomberg School of Public Health. While ... that time, the proportion of mishaps involving pilot error ... a pilots poor decision-making declined 71 percent. The researchers ...
... Philadelphia, December 28, 2007 Laser surgery to correct ... 1990s. Photorefractive Keratotomy (PRK) is typically used to correct ... is preferred for high myopia corrections. Although over 18 ... still some controversy regarding the maximum correction possible and ...
... Mansfield Methodist Medical,Center is one year old today ... into,the world, performed 1,600 surgeries, and treated nearly ... the largest employers in Mansfield with more,than 400 ... addition,278 independently practicing physicians have joined the medical ...
Cached Medicine News:Health News:'Philadelphia Ronald McDonald House(R) at Front & Erie' Celebrates Grand Opening 2Health News:The Healthy Monday Movement Offers a Unique New Year's Idea to All Americans 2Health News:Handling pesticides associated with greater asthma risk in farm women 2Health News:Pilot error declines as factor in airline mishaps 2Health News:LASIK works well, according to long-term study of highly myopic patients 2Health News:Methodist Mansfield Celebrates First Year 2Health News:Methodist Mansfield Celebrates First Year 3
(Date:2/27/2015)... , Feb. 27, 2015  Boston Scientific Corporation (NYSE: ... the Barclays 2015 Annual Healthcare Conference on March 10 ... Dan Brennan , executive vice president and chief ... Investor Relations, will participate in a 25-minute question and ... at approximately 1:05 p.m. ET. Following a 5-minute break, ...
(Date:2/27/2015)... --  Synageva BioPharma Corp. (Synageva) (NASDAQ: ... products for rare diseases, joins the National Organization ... Rare Diseases™ (EURORDIS™), The Global Genes Project™, and ... Day. On the last day of ... participants conduct special events to raise awareness and ...
(Date:2/27/2015)... , Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. (the ... company, today announced financial results for its first quarter ... three months ended December 31, 2014, revenue was $1,336,685. ... was $229,820 or $0.02 per share.  ... "I am very pleased with the significant progress we ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3
... MOUNTAIN VIEW, Calif. , Aug. 3 ... today announced it has been ranked in the top three ... to KLAS, a research firm specializing in monitoring and reporting ... the healthcare field, ZONARE has emerged as a real option ...
... HAIKOU CITY, China , Aug. 3 /PRNewswire-Asia-FirstCall/ -- ... which develops,manufactures, and markets specialty pharmaceutical products in China , today,announced that ... on Tuesday, August 10, 2010 . , ... The Company will hold a conference ...
Cached Medicine Technology:ZONARE Ranks in Top 3 in KLAS 2010 Ultrasound Report 2ZONARE Ranks in Top 3 in KLAS 2010 Ultrasound Report 3China Pharma Holdings, Inc. to Report Second Quarter 2010 Financial Results on August 10, 2010 2China Pharma Holdings, Inc. to Report Second Quarter 2010 Financial Results on August 10, 2010 3
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the...
The ACMI™ Operative Laparoscopy System is designed for single- and dual-incision CO2 laser procedures and is used with 45cm laparoscopic instruments....
The edge-to-edge clarity of the laparoscopes provides excellent image definition.Even small structures are easily recognized due to the optimal depth of focus. The outstanding optical quality provide...
Stryker bariatric laparoscopes set the standard in picture quality....
Medicine Products: